Show simple item record

dc.contributor.authorNikolopoulos, Georgios K.en
dc.contributor.authorBonovas, Stefanosen
dc.contributor.authorTsantes, Argirio E.en
dc.contributor.authorSitaras, N. M.en
dc.creatorNikolopoulos, Georgios K.en
dc.creatorBonovas, Stefanosen
dc.creatorTsantes, Argirio E.en
dc.creatorSitaras, N. M.en
dc.date.accessioned2018-06-22T09:54:04Z
dc.date.available2018-06-22T09:54:04Z
dc.date.issued2009
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/42181
dc.description.abstractDespite the considerable progress in antiretroviral therapy, the eradication of HIV-1 remains unfeasible. Therefore, novel agents are under investigation. The aim of this review is to summarize the conventional compounds, to describe the recently approved agents, and to take a comprehensive look at the clinically relevant findings of current research. © 2009 Bentham Science Publishers Ltd.en
dc.language.isoengen
dc.sourceMini-Reviews in Medicinal Chemistryen
dc.subject2
dc.subject3
dc.subject5
dc.subjectUnited statesen
dc.subjectHumanen
dc.subjectHumansen
dc.subjectClinical trialen
dc.subjectReviewen
dc.subjectLamivudineen
dc.subjectUnindexed drugen
dc.subjectZidovudineen
dc.subjectReceptorsen
dc.subjectUnclassified drugen
dc.subjectPlaceboen
dc.subjectHiv infectionsen
dc.subjectDrug researchen
dc.subjectDrug withdrawalen
dc.subjectDrug approvalen
dc.subjectFood and drug administrationen
dc.subjectUnspecified side effecten
dc.subjectAnimalsen
dc.subjectHighly active antiretroviral therapyen
dc.subjectHiven
dc.subjectAnti-hiv agentsen
dc.subjectHuman immunodeficiency virus 1en
dc.subjectIndinaviren
dc.subjectHiv-1en
dc.subjectAntiretrovirus agenten
dc.subjectEmtricitabineen
dc.subjectVirus replicationen
dc.subjectAcquired immune deficiency syndromeen
dc.subject4 tetrahydroquinolineen
dc.subject6 dihydroazacitidineen
dc.subject8 [(4 aminobutyl)(2 benzimidazolylmethyl)amino] 1en
dc.subjectAmprenavir phosphateen
dc.subjectAntiretroviralsen
dc.subjectAntiviral resistanceen
dc.subjectApricitabineen
dc.subjectAtazanaviren
dc.subjectBevirimaten
dc.subjectCcr5en
dc.subjectCxcr4en
dc.subjectDelavirdineen
dc.subjectDrug substitutionen
dc.subjectEfavirenzen
dc.subjectElvitegraviren
dc.subjectElvucitabineen
dc.subjectEradication therapyen
dc.subjectEtravirineen
dc.subjectHuman immunodeficiency virus 1 infectionen
dc.subjectIbalizumaben
dc.subjectIntegrase inhibitorsen
dc.subjectK 1212en
dc.subjectLopinavir plus ritonaviren
dc.subjectMaravirocen
dc.subjectMaturation inhibitorsen
dc.subjectNelfinaviren
dc.subjectNevirapineen
dc.subjectPro 140en
dc.subjectProtease inhibitorsen
dc.subjectRaltegraviren
dc.subjectReverse transcriptase inhibitorsen
dc.subjectRilpivirineen
dc.subjectRitonaviren
dc.subjectSaquinaviren
dc.subjectTipranaviren
dc.subjectVicrivirocen
dc.subjectEfavirenz plus emtricitabine plus tenofovir disoproxilfr
dc.titleHIV/AIDS: Recent advances in antiretroviral agentsen
dc.typeinfo:eu-repo/semantics/article
dc.description.volume9
dc.description.issue8
dc.description.startingpage900
dc.description.endingpage910
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidNikolopoulos, Georgios K.[0000-0002-3307-0246]
dc.contributor.orcidBonovas, Stefanos [0000-0001-6102-6579]
dc.gnosis.orcid0000-0002-3307-0246
dc.gnosis.orcid0000-0001-6102-6579


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record